On July 16, 2023, Fan Xiaoyang, deputy mayor of Tengzhou City Government of Shandong Province, Xu Jun, Party secretary and chairman of Tengzhou Xinhua Investment Group, Liu Hao, deputy general manager of Tengzhou Xinhua Investment Group, chairman of Shandong Xinhua Financial Investment Holding Company, and Gaisu, general manager of Guoxin Guoxin Investment Management Co., Ltd. visited our Hebei Langfang demonstration production base.

On July 17, 2023, Ding Guozhen, secretary of the Party Working Committee and director of the Management Committee of Wuwei Industrial Park in Gansu Province, and other three people visited our demonstration production base in Langfang, Hebei.

Today, Zhu Shoujiang, Deputy Secretary of the Party Group and Deputy Director of the Standing Committee of Xiangyang Municipal People's Congress, Li Shaoping, Director of Xiangyang Municipal Health Care Commission, Hu Xiaolan, Standing Committee Member and Executive Vice Mayor of Xiancheng District, Liu Yinghao, Standing Committee Member and Minister of United Front Work of Xiancheng District, and other 6 people came to our Shanghai headquarters for a visit.

As a high-tech enterprise focusing on the manufacture of "plant hollow capsules", our company is a natural medicinal excipient, extracted from plants without any animal ingredients, which can meet the needs of people with vegetarian culture and special religious groups such as Muslims and Jews. At the same time, it has the advantages of good universality, stable physical and chemical properties, no chemical residues, no bacterial microbial contamination, etc. It is widely used in the fields of drugs, health care products and nutritional supplements, and is very suitable for the filling of Chinese medicine preparations and biological preparations.

In the international pharmaceutical industry chain restructuring, drug research and development and manufacturing of some parts of the trend of continuous transfer to developing countries, China has become a key area of global pharmaceutical industry transfer due to its cost advantage, sufficient professional and technical personnel, rich production experience, and huge market potential. Therefore, the future expansion of the scale of preparation production will certainly drive the growth of China's pharmaceutical excipients market demand, and the growth of new pharmaceutical excipients will be more rapid.

In the past, there was a long-standing concept of "emphasis on raw materials, light on excipients" in the development of China's pharmaceutical industry. With the revision of the Chinese Pharmacopoeia (2020 edition), the new version of the pharmacopoeia has put forward new standards and requirements for the development of pharmaceutical excipients, which has increased the attention of pharmaceutical excipients in the whole industry.

Recently, Xie Hongyuan, deputy director of the Management Committee of Huaian Airport Industrial Park, visited Tsuen Jikang for investigation and visit. As a high-tech enterprise focusing on the research and development and production of medicinal excipients plant hollow capsules, Tsuen Jikang has independent intellectual property rights and advanced production technology, and its products are mainly exported to Europe and America.

Recently, Yang Hancheng, a member of the Standing Committee of Xianju County Committee of the Communist Party of China, Zheng Qian, vice chairman of the Xianju CPPCC, and other delegations visited Shanghai Quanjikang Pharmaceutical Technology Co., LTD.

Henan Science and Technology Investment Co., Ltd. has invested in new materials, new energy and other industries. As a high-tech enterprise with multiple attributes such as biomedicine and new materials, our company has independent intellectual property rights in the hollow capsule project of medicinal excipients.